Qube Research & Technologies (QRT)
OBIO icon

Qube Research & Technologies (QRT)’s Orchestra BioMed OBIO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-108,953
Closed -$463K – 3890
2026
Q1 		$463K Buy
108,953
+2,211
+2% +$9.41K ﹤0.01% 2762
2025
Q4 		$443K Buy
106,742
+80,808
+312% +$326K ﹤0.01% 2837
2025
Q3 		$64.3K Buy
+25,934
New +$71.5K ﹤0.01% 3141

Other funds holding OBIO

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OBIO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Orchestra BioMed (OBIO) in Q2 2026, closing a stake of 108,953 shares — an estimated $463K sold.

Qube Research & Technologies (QRT) first reported a position in OBIO in Q3 2025 and held it in 3 quarters. The position peaked at $463K in Q1 2026. 77 funds tracked by Wall St. Rank hold OBIO as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Orchestra BioMed position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 108,953 Orchestra BioMed shares in Q2 2026, an estimated $463K.
  • Qube Research & Technologies (QRT) first reported a position in Orchestra BioMed in Q3 2025 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Orchestra BioMed position peaked at $463K in Q1 2026.
  • 77 funds tracked by Wall St. Rank held Orchestra BioMed as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.